Among the mechanisms that may explain this relationship in humans we found supporting evidence that follistatin induces insulin resistance in adipose tissue, thereby, promoting adipose tissue lipolysis and NAFLD. This evidence concerns the gene FST and metabolic dysfunction-associated steatotic liver disease.